side effects of stopping glp-1 withdrawal can have lasting health The Promise of Weight-Loss Drugs

Zepbound (Tirzepatide) has shown promising results for individuals struggling with weight loss

Mortality Implications Life actuaries are focused on whether GLP-1 drugs will measurably affect long-term mortality

Most research protocols cap single shots around 300 mcg because GH release flattens out beyond that point more dose does not equal more GH pulse

The emergence of pancreatitis in this population raises questions about whether the drugs risk-benefit profile was appropriately communicated and whether additional warnings should have been implemented as prescribing patterns shifted

This multifaceted approach makes them effective for both glycaemic control and weight reduction